AstraZeneca PLC (AZN)vsLifestance Health Group Inc (LFST)
AZN
AstraZeneca PLC
$160.17
+0.33%
HEALTHCARE · Cap: $252.33B
LFST
Lifestance Health Group Inc
$12.97
-0.23%
HEALTHCARE · Cap: $4.82B
Smart Verdict
WallStSmart Research — data-driven comparison
AstraZeneca PLC generates 3772% more annual revenue ($61.37B vs $1.58B). AZN leads profitability with a 17.0% profit margin vs 3.2%. AZN trades at a lower P/E of 24.3x. AZN earns a higher WallStSmart Score of 60/100 (C+).
AZN
Buy60
out of 100
Grade: C+
LFST
Hold48
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+18.4%
Fair Value
$196.10
Current Price
$160.17
$35.93 discount
Margin of Safety
+36.0%
Fair Value
$10.83
Current Price
$12.97
$2.14 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Every $100 of equity generates 21 in profit
Strong operational efficiency at 23.5%
Generating 2.1B in free cash flow
Earnings expanding 1927.0% YoY
Conservative balance sheet, low leverage
Revenue surging 26.1% year-over-year
Areas to Watch
2.5% earnings growth
Distress zone — elevated risk
Distress zone — elevated risk
ROE of 1.6% — below average capital efficiency
3.2% margin — thin
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : AZN
The strongest argument for AZN centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 17.0% and operating margin at 23.5%. PEG of 1.28 suggests the stock is reasonably priced for its growth.
Bull Case : LFST
The strongest argument for LFST centers on EPS Growth, Debt/Equity, Revenue Growth. Revenue growth of 26.1% demonstrates continued momentum.
Bear Case : AZN
The primary concerns for AZN are EPS Growth, Altman Z-Score.
Bear Case : LFST
The primary concerns for LFST are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 97.1x leaves little room for execution misses. Thin 3.2% margins leave little buffer for downturns.
Key Dynamics to Monitor
AZN profiles as a mature stock while LFST is a growth play — different risk/reward profiles.
LFST carries more volatility with a beta of 1.22 — expect wider price swings.
LFST is growing revenue faster at 26.1% — sustainability is the question.
AZN generates stronger free cash flow (2.1B), providing more financial flexibility.
Bottom Line
AZN scores higher overall (60/100 vs 48/100), backed by strong 17.0% margins. LFST offers better value entry with a 36.0% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
AstraZeneca PLC
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide. The company is headquartered in Cambridge, the United Kingdom.
Lifestance Health Group Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
LifeStance Health Group, Inc., provides outpatient mental health services to children, adolescents, adults and geriatrics. The company is headquartered in Scottsdale, Arizona.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?